|
Integrated Pharmaceuticals, Inc. Announces
its First Product Shipment
FITCHBURG, Mass, Jan. 5 /PRNewswire-FirstCall/
-- Integrated Pharmaceuticals, Inc. (IntePharm) (OTC.PK: INTP)
announced that in December 2004 it completed its first commercial
shipment of products made at its new production facility in
Fitchburg, MA. IntePharm started construction of its Fitchburg
facility in the spring of 2004. The shipment of this product
represents a major milestone for the Company, demonstrating
the scalability of its technology, the readiness of its production
facility, and the effectiveness of its sales team.
Dr. Chinmay Chatterjee, Ph.D., President
and CEO of IntePharm said: "We are excited about having
reached this milestone. We are also in discussions with several
other potential customers. These discussions are at various
stages of approval and negotiations concerning sales terms
and conditions."
Dr. Chatterjee continued: "IntePharm
takes pride in providing the highest quality products to its
customers. In order to maintain these high standards, all
of IntePharm's products and product ingredients must pass
a series of strict quality control tests to confirm that our
products meet the appropriate level of quality. Our commitment
to quality is unsurpassed."
About the Company
IntePharm is an emerging producer of pharmaceuticals,
specialty compounds and chemicals for the pharmaceutical,
neutraceutical and food industries. In addition to making
products, IntePharm discovers and develops more efficient
and cost-effective manufacturing processes. These processes
are developed using a comprehensive technology platform that
combines metabolic engineering, cellular genetics, advanced
bioprocess engineering, and computer simulation science.
For further information please contact Dr.
Chinmay Chatterjee, Integrated Pharmaceuticals, Inc. at (978)
696-0020, or visit http://www.intepharm.com.
Forward-Looking Statements
Certain statements contained in this press
release that are not historical facts constitute "Forward-Looking
Statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements,
in general, predict, indicate or imply future results, performance
or achievements and generally use words so indicative. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual
results or performance of the Company and its business to
be materially different from that expressed or implied by
such forward-looking statements. Included in those factors
are the following: our dependence on a limited number of potential
customers; limited managerial experience of our executives;
possible needs for additional capital; possible delays in
product development and delivery schedules; deferred or lost
sales because of the complex sales process prevalent in the
industries that we seek to serve; increased competitive pressure;
and rapid technological changes. Forward-looking statements
by their very nature are uncertain. There can be no guarantee
that any forward-looking statement will be fulfilled. The
Company assumes no obligation to update forward-looking statements
to reflect actual results or changes in or additions to the
factors affecting such forward-looking statements.
SOURCE Integrated Pharmaceuticals, Inc.
Web Site: http://www.intepharm.com
Copyright © 1996-2004 PR Newswire Association
LLC. All Rights Reserved. A United Business Media company.
|
